溃疡性结肠炎的方方面面.ppt
《溃疡性结肠炎的方方面面.ppt》由会员分享,可在线阅读,更多相关《溃疡性结肠炎的方方面面.ppt(85页珍藏版)》请在冰豆网上搜索。
![溃疡性结肠炎的方方面面.ppt](https://file1.bdocx.com/fileroot1/2022-10/8/4577c08f-13e8-47b5-95cb-497a9ec70f5b/4577c08f-13e8-47b5-95cb-497a9ec70f5b1.gif)
溃疡性结肠炎溃疡性结肠炎IntroductionIntroductionnIBDIBD是一是一种种病因病因尚尚不十分不十分清清楚的慢性非特楚的慢性非特异异性性肠道炎症,包括道炎症,包括UCUC和和CDCD。
n其其发病率呈逐年上升病率呈逐年上升趋势,且多,且多为青壮青壮年年发病,病,临床表床表现复复杂,并并发症症严重,重,肠外表外表现多多样,严重影重影响个响个人生活人生活质量和社量和社会会生生产力。
力。
n此外,因其有癌此外,因其有癌变的的风险,备受广大受广大医医生的重生的重视。
n近年来在国内外近年来在国内外IBDIBD基础与临床研究高潮迭起,基础研究的成果直接指向临基础与临床研究高潮迭起,基础研究的成果直接指向临床治疗,取得了划时代的进展。
床治疗,取得了划时代的进展。
n探讨和摸索适合国人的治疗方案以降低重症探讨和摸索适合国人的治疗方案以降低重症UCUC的并发症和死亡率显得十分的并发症和死亡率显得十分重要。
重要。
IntroductionnUlcerativecolitisischaracterizedbymucosalinflammationofthecolon.nThepathologyisinflammatoryandthediseasecourseisrelapsingandremittingwithintermittentsymptomsofrectalbleedinganddiarrhea.nApproximately25%ofpatientsdevelopachronicactiveorarapidlyfulminatediseasecourse.nChronicinflammationcanleadtodysplasiaandcancer.nApproximately20%ofpatientsrequirecolectomywithileoanalpouchorstoma.nVelayosFS,TerdimanJP,WalshJM.Effectof5-aminosalicylateuseoncolorectalcanceranddysplasiarisk:
asystematicreviewandmetaanalysisofobservationalstudies.AmJGastroenterol2005;100:
13451353.ConsensusConsensusnStangeEF,TravisSP,VermeireS,ReinischW,GeboesK,BarakauskieneA,etal.Europeanevidence-basedConsensusonthediagnosisandmanagementofulcerativecolitis:
definitionsanddiagnosis.JCrohnsColitis2008;2:
123.nVanAsscheG,DignassA,PanesJ,eta1ThesecondEuropeanevidence-basedConsensusonthediagnosisandmanagementofulcerativecolitis:
DefinitionsanddiagnosisJCrohnsColitis,20104:
727nMowatC,ColeA,WindsorA,AhmadT,ArnottI,DriscollR,etal.Guidelinesforthemanagementofinflammatoryboweldiseaseinadults.Gut2011;60:
571607.nTurnerD,LevineA,EscherJC,GriffithsAM,RussellRK,DignassA,etal.Managementofpediatriculcerativecolitis:
ajointECCOandESPGHANevidence-basedconsensusguidelines.JPediatrGastroenterolNutr2012.nTurnerD,TravisSP,GriffithsAM,RuemmeleFM,LevineA,BenchimolEI,etal.Consensusformanagingacutesevereulcerativecolitisinchildren:
asystematicreviewandjointstatementfromECCO,ESPGHAN,andthePortoIBDWorkingGroupofESPGHAN.AmJGastroenterol2011;106:
57488.ManagementconsensusofinflammatoryboweldiseaseforManagementconsensusofinflammatoryboweldiseasefortheAsiaPacificregiontheAsiaPacificregion20062006nAbstract:
Atthepresenttherearenolarge-scaleepidemiologicdataoninflammatoryboweldisease(IBD)intheAsiaPacificregion,butseveralstudieshaveshownanincreasedincidenceandprevalenceofIBDinthisregion.nComparedtotheWest,thereappearstoexistatimelagphenomenon.WithregardtothetwomainformsofIBD,ulcerativecolitis(UC)ismoreprevalentthanCrohnsdisease(CD).Inadditiontogeographicdifferences,ethnicdifferenceshavebeenobservedinthemultiracialAsiancountries.Moreover,thegeneticbackgroundsaredifferentintheAsiancomparedtoWesternpatients.Forinstance,NOD2/CARD15variantshavenotbeenfoundinAsianCDpatients.nIngeneral,theclinicalcourseofIBDseemstobelesssevereintheAsiaPacificregionthaninWesterncountries.nDiagnosisofIBDinthisregionposesspecialproblems.ThelackofagoldstandardforthediagnosisofIBD,andtheexistenceofavarietyofinfectiousenterocolitiswithsimilarmanifestationstothoseofIBDmakethedifferentialdiagnosisparticularlydifficult.Sofar,nWesterndiagnosticcriteriahavebeenintroducedforthediagnosisofIBD.Astepwiseapproachtoexcludenon-IBDenterocolitisalsomustbeintroduced,andadefinitediagnosismustincludetypicalhistologicalfeatures.Insomepatients,followupandtherapeutictrialsmightbenecessarytoobtainadefinitivediagnosis.AbetterunderstandingofthepathogenesisofIBDwillallowthedevelopmentofbetterdiagnosticmarkers.nThemanagementofIBDalsoposessomespecialproblemsintheAsiaPacificRegion.ThereisoftenadelayinusingpropermedicationsforIBD,andalternativelocalremediesarestillwidelyused.WithacombinationofWesternguidelinesandregionalexperiences,similarprinciplescanbeusedforinductionandmaintenanceofremission.Astepwiseselectionofmedicationsisadvocateddependingontheextent,activityandseverityofthedisease.ComprehensiveandindividualizedapproachesaresuggestedfordifferentIBDpatients.nDeeperunderstandingofdiseasepathogenesisandtheuniquecharacteristicsofIBDintheAsiaPacificregion,combinedwithreasonableandpracticalguidelinesfordrugmanagementandthefutureuseofbiologicalagentswouldimprovethetherapeuticoutlookofIBDinthisregion.TheAsia-Pacificconsensusonulcerativecolitis2010Europeanevidence-basedconsensusontheEuropeanevidence-basedconsensusonthediagnosis/managementofulcerativecolitis2008diagnosis/managementofulcerativecolitis2008nThisdocumentsetsoutthecurrentEuropeanConsensusonthediagnosisandmanagementofUC,reachedbytheEuropeanCrohnsandColitisOrganisation(ECCO)atameetingheldinBerlinon20thOctobe